CAR Treg-cell therapy (TxCell/University of Lubeck)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCAR Treg-cell therapy (TxCell/University of Lubeck)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionForkhead box protein P3 modulators
TargetsForkhead box protein P3
Therapy Area/IndicationsPemphigoid, Bullous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSangamo Therapeutics France Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of LubeckSangamo Therapeutics France Sas
Active IndicationsN/A
Inactive IndicationsPemphigoid, Bullous

Other Information

ATC CodeN/A
Related LinksN/A